Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 340 Lymphoma, Non-Hodgkin 295 Precursor Cell Lymphoblastic Leukemia-Lymphoma 249 Leukemia, Lymphocytic, Chronic, B-Cell 235 Lymphoma, Large B-Cell, Diffuse 217 Leukemia 186 Lymphoma, Follicular 183 Lymphoma, Mantle-Cell 167 Recurrence 142 Hodgkin Disease 141 Lymphoma, B-Cell 139 Leukemia, Myeloid, Acute 133 Burkitt Lymphoma 120 Lymphoma, B-Cell, Marginal Zone 94 Multiple Myeloma 86 Myelodysplastic Syndromes 83 Waldenstrom Macroglobulinemia 62 Lymphoma, T-Cell, Peripheral 57 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 52 Neoplasms 52 Lymphoma, T-Cell, Cutaneous 52 Hematologic Neoplasms 49 Lymphoma, Large-Cell, Anaplastic 43 Lymphoma, T-Cell 41 Lymphoma, Large-Cell, Immunoblastic 41 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40 Mycosis Fungoides 38 Leukemia, B-Cell 34 Sezary Syndrome 30 Myeloproliferative Disorders 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Malaria × Lymphoid × Clear all

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed

Burkitt Lymphoma, Malaria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡